ITCMDBv1
Clinical TrialID 752

The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels

NCT01106703

Asymptomatic Subjects With Atopy and Elevated Serum IgE

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
752
Evidence Id
752
Core Evidence Id
752
Source Clinical Trial Id
736
Herb2 Clinical Trial Id
HBCT000736
Nct Id
NCT01106703
Title
The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels
Status
Completed
Phase
Phase 2
Study Result
No
Study Condition
Asymptomatic Subjects With Atopy and Elevated Serum IgE
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: PG102, a water soluble extract from Actinidia arguta|OTHER: placebo
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Double
Intervention Purpose
Prevention
Gender
All
Age
Adult, Older_Adult
Enrollment
90
Outcome Measure
serum total IgE level, 8weeks
Sponsor Collaborator
Seoul National University Hospital|Ministry of Health & Welfare, Korea
Funded By
OTHER
Location
Soeul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of
Other Id
A060655
Start Date
2006-12
Primary Completion Date
2008-03
Completion Date
2008-04
First Posted
2010-04-20
Results First Posted
Last Update Posted
2010-07-27
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01106703
Title Cn
Title En
The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels
Bilingual Status
semi_complete